CURLF
Curaleaf Holdings, Inc.
$3.32
-2.06%
No data for this timeframe.
Vol
SEC Reports6
Exchange OTC·Sector Medicinal Chemicals & Botanical Products·Inc. A1·CIK 0001756770·Prev Close $3.39
Recent Activity
May 18, 2026
SEC
Curaleaf filed proxy materials for its June 22, 2026 annual general and special meeting, seeking shareholder approval fo
6-K — Impact 4/10
May 11, 2026
SEC
Curaleaf Holdings filed a 6-K announcing the resignation of its independent auditor, PKF O'Connor Davies, LLP, effective
6-K — Impact 2/10
May 5, 2026
SEC
Curaleaf announced its Annual and Special Shareholders Meeting for June 22, 2026, with proposals including the redomicil
6-K — Impact 3/10
Apr 29, 2026
short_interest
FTD: CURLF — 290,040 shares ($1.0M) failed to deliver
Settlement: 20260429, Price: $3.30, FTD Value: $957,132, CURALEAF HLDGS INC (CANADA)
Price Targets
Historical data — last covering-analyst action Aug 2024. No current recommendation available.
$5.00 (Aug 2024)
Current $3.32
Low $5.00
Median $5.00
High $5.00
2 analysts
$5.00
$5.00
Analyst Ratings
2Strong Buy
9Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Aug 8, 2024 | Needham | REITERATE | Buy → Buy |
| May 10, 2024 | Needham | MAINTAIN | Buy → Buy |
| Mar 8, 2024 | Wedbush | MAINTAIN | Outperform → Outperform |
| Mar 7, 2024 | Craig-Hallum | MAINTAIN | Hold → Hold |
| Mar 7, 2024 | Needham | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.08 | $-0.08 — $-0.08 | -28% YoY | 1 |
| Next Q | $-0.07 | $-0.07 — $-0.07 | -10% YoY | 1 |
| Current FY | $-0.11 ▲ +64.6% | $-0.13 — $-0.09 | 52% YoY | 2 |
| Next FY | $-0.22 ▲ +17.2% | $-0.24 — $-0.19 | -96% YoY | 2 |
Latest Reports
NEUTRAL
6-K
4/10
Curaleaf filed proxy materials for its June 22, 2026 annual general and special meeting, seeking shareholder approval fo
May 18, 2026
NEUTRAL
6-K
2/10
Curaleaf Holdings filed a 6-K announcing the resignation of its independent auditor, PKF O'Connor Davies, LLP, effective
May 11, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
6 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 5 neutral. Avg impact: 3.3/10.
NEUTRAL
6-K
4/10
Curaleaf filed proxy materials for its June 22, 2026 annual general and special meeting, seeking sha
May 18, 2026
NEUTRAL
6-K
2/10
Curaleaf Holdings filed a 6-K announcing the resignation of its independent auditor, PKF O'Connor Da
May 11, 2026
NEUTRAL
6-K
3/10
Curaleaf announced its Annual and Special Shareholders Meeting for June 22, 2026, with proposals inc
May 5, 2026
NEUTRAL
6-K
2/10
Curaleaf appointed Torsten Greif, co-founder of its German subsidiary Four 20 Pharma, to the Board o
May 5, 2026
NEUTRAL
6-K
4/10
Curaleaf completed the buyout of the remaining 45% stake in German medical cannabis firm Four 20 Pha
May 5, 2026
BULLISH
6-K
5/10
Curaleaf Holdings has announced a $83 million share repurchase program, authorizing the repurchase o
Apr 17, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Aug 2024): 92% buy across 12 analysts — 2 strong buy, 9 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Aug 2024. No current recommendation available.
$5.00 mean target (Aug 2024)
$5.00 Low
$5.00 High
| Metric | Value |
|---|---|
| Current Price | $3.32 |
| Target Low | $5.00 |
| Target Mean | $5.00 |
| Target Median | $5.00 |
| Target High | $5.00 |
| # Analysts | 2 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.08 | $-0.08 | $-0.08 | -28.0% | +0.0% | 0↑ 1↓ | $0.3B | 5.6% | 1 |
| Next Q 2026-09-30 |
$-0.07 | $-0.07 | $-0.07 | -10.2% | +0.0% | 0↑ 1↓ | $0.3B | 5.2% | 1 |
| Current FY 2026-12-31 |
$-0.11 | $-0.13 | $-0.09 | 52.3% | +64.6% | 1↑ 0↓ | $1.3B | 5.7% | 2 |
| Next FY 2027-12-31 |
$-0.22 | $-0.24 | $-0.19 | -96.3% | +17.2% | 1↑ 0↓ | $1.4B | 8.1% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.080 | |
| 7d ago | $-0.080 | |
| 30d ago | $-0.080 | |
| 60d ago | $-0.080 | |
| 90d ago | $-0.070 | -0.010 |
11 analyst firms have rated this stock: 1 upgrades, 1 downgrades, 7 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Aug 8, 2024 | Needham | REITERATE | Buy | Buy |
| May 10, 2024 | Needham | MAINTAIN | Buy | Buy |
| Mar 8, 2024 | Wedbush | MAINTAIN | Outperform | Outperform |
| Mar 7, 2024 | Craig-Hallum | MAINTAIN | Hold | Hold |
| Mar 7, 2024 | Needham | MAINTAIN | Buy | Buy |
| Aug 10, 2023 | Needham | REITERATE | Buy | Buy |
| May 19, 2023 | Wedbush | REITERATE | Outperform | Outperform |
| May 19, 2023 | Benchmark | DOWNGRADE | Buy | Hold |
| May 18, 2023 | Needham | REITERATE | Buy | Buy |
| May 2, 2023 | Needham | MAINTAIN | — | Buy |
| Apr 14, 2023 | Alliance Global Partners | MAINTAIN | — | Buy |
| Apr 14, 2023 | Wedbush | REITERATE | — | Outperform |
| Dec 30, 2022 | Cantor Fitzgerald | MAINTAIN | — | Overweight |
| Dec 2, 2022 | Wedbush | INITIATE | — | Outperform |
| Nov 8, 2022 | Cantor Fitzgerald | MAINTAIN | — | Overweight |
| Oct 28, 2022 | Cantor Fitzgerald | MAINTAIN | — | Overweight |
| Aug 9, 2022 | Cantor Fitzgerald | MAINTAIN | — | Overweight |
| Jul 22, 2022 | Seaport Global | INITIATE | — | Buy |
| May 10, 2022 | Cantor Fitzgerald | MAINTAIN | — | Overweight |
| May 10, 2022 | Needham | MAINTAIN | — | Buy |
| Apr 25, 2022 | Cantor Fitzgerald | MAINTAIN | — | Overweight |
| Mar 4, 2022 | Needham | MAINTAIN | — | Buy |
| Mar 4, 2022 | Cantor Fitzgerald | MAINTAIN | — | Overweight |
| Jan 7, 2022 | Wolfe Research | INITIATE | — | Peer Perform |
| Jan 4, 2022 | Cantor Fitzgerald | MAINTAIN | — | Overweight |
| Nov 3, 2021 | Cantor Fitzgerald | MAINTAIN | — | Overweight |
| Oct 8, 2021 | Needham | MAINTAIN | — | Buy |
| Mar 10, 2021 | Cantor Fitzgerald | MAINTAIN | — | Overweight |
| Mar 10, 2021 | Needham | MAINTAIN | — | Buy |
| Jan 20, 2021 | Roth Capital | MAINTAIN | — | Buy |
| Jan 20, 2021 | Cantor Fitzgerald | MAINTAIN | — | Overweight |
| Nov 18, 2020 | Needham | MAINTAIN | — | Buy |
| Nov 18, 2020 | Cantor Fitzgerald | MAINTAIN | — | Overweight |
| Aug 18, 2020 | Needham | MAINTAIN | — | Buy |
| Aug 18, 2020 | Cantor Fitzgerald | UPGRADE | Neutral | Overweight |
| Aug 6, 2020 | Needham | MAINTAIN | — | Buy |
| Aug 4, 2020 | Cantor Fitzgerald | MAINTAIN | — | Neutral |
| May 19, 2020 | Cantor Fitzgerald | MAINTAIN | — | Neutral |
| May 19, 2020 | Needham | MAINTAIN | — | Buy |
| May 12, 2020 | Needham | MAINTAIN | — | Buy |
| Mar 25, 2020 | Cantor Fitzgerald | REITERATE | — | Neutral |
| Feb 14, 2020 | Cantor Fitzgerald | INITIATE | — | Neutral |
| Dec 3, 2019 | Needham | INITIATE | — | Buy |
| Sep 20, 2019 | MKM Partners | INITIATE | — | Sell |
| Jun 11, 2019 | Compass Point | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 2 | 9 | 1 | 0 | 0 | 92% | |
| Apr 1, 2026 | 2 | 9 | 1 | 0 | 0 | 92% | |
| Mar 1, 2026 | 2 | 9 | 1 | 0 | 0 | 92% | |
| Feb 1, 2026 | 2 | 9 | 1 | 0 | 0 | 92% | |
| Jan 1, 2026 | 2 | 9 | 1 | 0 | 0 | 92% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Apr 29, 2026
short_interest
FTD: CURLF — 290,040 shares ($1.0M) failed to deliver
Settlement: 20260429, Price: $3.30, FTD Value: $957,132, CURALEAF HLDGS INC (CANADA)
Mar 31, 2026
short_interest
FTD: CURLF — 267,193 shares ($0.5M) failed to deliver
Settlement: 20260331, Price: $1.89, FTD Value: $504,994.77, CURALEAF HLDGS INC (CANADA)
Feb 20, 2026
short_interest
FTD: CURLF — 253,977 shares ($0.7M) failed to deliver
Settlement: 20260220, Price: $2.61, FTD Value: $662,879.97, CURALEAF HLDGS INC (CANADA)
Feb 12, 2026
short_interest
FTD: CURLF — 988,959 shares ($2.4M) failed to deliver
Settlement: 20260212, Price: $2.43, FTD Value: $2,403,170.37, CURALEAF HLDGS INC (CANADA)